- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Mix-up leads to nationwide azathioprine recall
A lot of azathioprine 50-mg tablets (Lot 558470A, Exp. March 2009) has been recalled by Roxane Laboratories after the company discovered a single bottle containing methotrexate 2.5-mg tablets.
Mix-up leads to nationwide azathioprine recall
A lot of azathioprine 50-mg tablets (Lot 558470A, Exp. March 2009) has been recalled by Roxane Laboratories after the company discovered a single bottle containing methotrexate 2.5-mg tablets. Information has been sent to pharmacists alerting them to the error and urging them to contact those patients who may have filled azathioprine prescriptions with tablets from the recalled lot. Pharmacists and wholesalers that have any bottles of the affected lot should discontinue distribution immediately and contact Capital Returns at 1-(800) 950-5479 (menu option 1).
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
